1 / 3

Atopic Dermatitis Market Forecast and Insights

Atopic Dermatitis (AD), also known as atopic eczema, is a type of inflammation of the skin (dermatitis). It results in itchy, red, swollen, and cracked skin. Clear fluid may come from the affected areas, which often thickens over time. While the condition may occur at any age, it typically starts in childhood with changing severity over the years.

xmichael
Download Presentation

Atopic Dermatitis Market Forecast and Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Atopic Dermatitis Market Atopic Dermatitis Atopic Dermatitis (AD), also known as atopic eczema, is a type of inflammation of the skin (dermatitis). It results in itchy, red, swollen, and cracked skin. Clear fluid may come from the affected areas, which often thickens over time. While the condition may occur at any age, it typically starts in childhood with changing severity over the years. In children under one year of age, much of the body may be affected. As children get older, the back of the knees and front of the elbows are the most common areas affected. Atopic Dermatitis Epidemiology Segmentation in the 7MM ● ● Prevalent Cases of Atopic Dermatitis Diagnosed Prevalent Cases of Atopic Dermatitis

  2. ● ● ● ● Severity-specific distribution of Atopic Dermatitis in Adults Severity-specific distribution of Atopic Dermatitis in Pediatric Population Gender-specific Prevalence of Atopic Dermatitis in Adults Diagnosed Prevalent Cases of Pruritus in Atopic Dermatitis Atopic Dermatitis Epidemiological Insights Observed in the 7MM (2021) ● The total diagnosed prevalent cases of Atopic Dermatitis in 7MM were estimated to be 65.4 million. The total diagnosed incident cases of Atopic Dermatitis in the US were found to be 24.1 million. The total diagnosed incident cases of Atopic Dermatitis in Germany were estimated to be 893K cases. The total diagnosed incident cases of Atopic Dermatitis in the UK were found to be 4 million. The total diagnosed incident cases of Atopic Dermatitis in Spain were estimated to be 3.8 million. The total diagnosed incident cases of Atopic Dermatitis in Japan were observed to be 2.2 million. ● ● ● ● ● Atopic Dermatitis Market Insight The market size of Atopic Dermatitis in the 7MM was found to be approximately USD 15,026 million in the year 2021. Atopic Dermatitis Market Drivers ● ● ● ● Rising prevalence of Atopic Dermatitis Escalating expenditure on healthcare Approvals of JAK inhibitors Potential Emerging Therapies for Atopic Dermatitis Atopic Dermatitis Market Barriers ● ● ● ● ● Over-the-counter medications Outdated treatment recommendations Poor prognosis and treatment adherence Lack of timely diagnosis Management of Atopic Dermatitis in the primary care setting Atopic Dermatitis Emerging Drugs The emerging drugs in the Atopic Dermatitis market are

  3. ● ● ● ● ● ● ● ● ● ● ● ● Ly3650150 Etrasimod FB825 Nemolizumab DS107 Bermekimab B244 KY1005 (Amlitelimab) Q301 Roflumilast Difelikefalin (Korsuva) Tradipitant, and many others Atopic Dermatitis Key Players The key players working in the Atopic Dermatitis market are ● ● ● ● ● ● ● ● ● ● ● ● Eli Lilly and Company Arena Pharmaceuticals Oneness Biotech Galderma DS Biopharma Janssen AOBiome Therapeutics Sanofi/Kymab Qurient Arcutis Biotherapeutics Cara Therapeutics Vanda Pharmaceuticals, and several others

More Related